|
KMID : 0352720190430030361
|
|
Journal of Ginseng Research
2019 Volume.43 No. 3 p.361 ~ p.367
|
|
|
Ginsenosides: the need to move forward from bench to clinical trials
|
|
Yu Seung-Eun
Mwesige Benjamin
Yi Young-Su
Yoo Byong-Chul
|
|
|
Abstract
|
|
|
|
Panax ginseng, known as Koran ginseng, one of the most commonly used traditional plants, has been demonstrated to show a wide range of pharmacological applications. Ginsenosides are the major active ingredients found in ginseng and are responsible for the biological and pharmacological activities, such as antioxidation, antiinflammation, vasorelaxation, and anticancer actions. Existing studies have mostly focused on identifying and purifying single ginsenosides and investigating pharmacological activities and molecular mechanisms in cells and animal models. However, ginsenoside studies based on clinical trials have been very limited. Therefore, this review aimed to discuss the currently available clinical trials on ginsenosides and provide insights and future directions for developing ginsenosides as efficacious and safe drugs for human disease.
|
|
|
KEYWORD
|
|
|
Clinical trial, Ginseng, Ginsenoside, Protopanaxadiol, Protopanaxatriol
|
|
|
FullTexts / Linksout information
|
|
|
|
|
Listed journal information
|
|
|
|